Vivos Therapeutics, Inc. (VVOS) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$21.17M | -90.1% |
| 2024 | -$11.14M | +18.0% |
| 2023 | -$13.58M | +43.0% |
| 2022 | -$23.84M | -17.5% |
| 2021 | -$20.29M | -68.3% |
| 2020 | -$12.06M | -12.1% |
| 2019 | -$10.75M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$21.17M | -90.1% |
| 2024 | -$11.14M | +18.0% |
| 2023 | -$13.58M | +43.0% |
| 2022 | -$23.84M | -17.5% |
| 2021 | -$20.29M | -68.3% |
| 2020 | -$12.06M | -12.1% |
| 2019 | -$10.75M | — |